<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Transforming growth factor-beta (TGF-beta) is a potent regulator of tissue homeostasis and can act as both a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor and a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> promoter </plain></SENT>
<SENT sid="1" pm="."><plain>The ability to induce cell cycle arrest is a major component of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor function of TGF-beta </plain></SENT>
<SENT sid="2" pm="."><plain>Lung, mammary, and skin epithelial cells exhibit a common minimal <z:chebi fb="0" ids="35610">cytostatic</z:chebi> program in response to TGF-beta signaling involving the repression of the growth-promoting factors c-MYC, Id1, Id2, and Id3 </plain></SENT>
<SENT sid="3" pm="."><plain>Loss of c-MYC expression is a pivotal event in this process, resulting in derepression of the cyclin-dependent kinase inhibitors CDKN1A (p21) and CDKN2B (p15) and ultimately leading to <z:mpath ids='MPATH_73'>growth arrest</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>It is not clear, however, which responses are necessary for TGF-beta-mediated <z:mpath ids='MPATH_73'>growth arrest</z:mpath> in other cell types </plain></SENT>
<SENT sid="5" pm="."><plain>Here, in human Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells transformed by deregulated c-MYC expression, we demonstrate that efficient TGF-beta-induced cytostasis can occur despite both maintenance of c-MYC levels and a lack of p21 and p15 induction </plain></SENT>
<SENT sid="6" pm="."><plain>TGF-beta treatment also results in induction, rather than repression, of Id1 and Id2 expression </plain></SENT>
<SENT sid="7" pm="."><plain>In this context, <z:mpath ids='MPATH_73'>growth arrest</z:mpath> correlates with transcriptional repression of E2F-1, and overexpression of E2F-1 in Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells largely overcomes the TGF-beta-mediated G(1) arrest phenotype </plain></SENT>
<SENT sid="8" pm="."><plain>These data indicate that deregulation of c-MYC in <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells does not overcome the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor function of TGF-beta and that repression of E2F-1 transcription is sufficient for the efficient induction of cytostasis </plain></SENT>
</text></document>